The Calmer Co International Limited (CCO) Earnings Call Transcript & Summary

February 5, 2026

Australian Securities Exchange AU Consumer Staples Personal Care Products earnings 34 min

Earnings Call Speaker Segments

Zane Yoshida

executive
#1

Our Chief Commercial Officer, Matthew Kowal, and I will be walking everyone through the results together. Thanks, Matt.

Matthew Kowal

executive
#2

Much appreciated.

Zane Yoshida

executive
#3

So, as we keep communicating with our shareholders and partners, we address the strategic pillars throughout the Calmer Co's business, beginning first with strategic Pillar 1, which covers regional sourcing, manufacturing excellence, and innovation capability within the company. We address strategic Pillar 2, which is our direct-to-consumer business, including Amazon. The third is profitable, scalable retail, and after that comes wholesale bulk ingredients. If I could give you a bit of an overview of some key progress across the strategic pillars, we keep building strength with our regional sourcing strategy, having now secured multiple orders of container loads of Noble Kava out of Papua New Guinea, with Vanuatu soon to follow. There's further news around the opening of borders as it relates to more regional supply into Fiji. During the quarter, SMO also had success with biosecurity, opening up potential supply into the Fiji market as well, given the consumption in Fiji, but also given the fact that Fiji is now becoming a central hub in the Pacific for processing and subsequent export into strategic locations around Australia, New Zealand, and the United States and, in some instances, parts of Europe as well.

Zane Yoshida

executive
#4

Additionally, this week we have begun consulting industry stakeholders regarding the Kava Bill. As a matter of fact, right now a consultation is taking place with growers, processors, and exporters at the Southern Cross Hotel in Suva, and members of our team are present there too. So it is excellent news that we have finally reached this point, with stakeholder consultation underway to advance toward a parliamentary review and final adoption of the Kava Bill, which matters a great deal for the Calmer Co and for the industry, since it gives us a strategic and regulatory framework to work toward so that we all meet international standards as we seek to strengthen exports further beyond U.S.A., New Zealand, and Australia, potentially into the European market too, which remains a work in progress. The direct-to-consumer strategy, Amazon included, is still a significant channel — in fact the most significant one — in the Calmer Co's business when it comes to revenue contribution. We will go into this in more detail during the presentation. But Amazon U.S.A. and the contribution it makes are becoming very meaningful, with U.S.A. now the top geographic location for the company in terms of revenue, as announced in the quarterly results. On the profitable, scalable retail side, we keep making very strong progress, and Matt will cover this in detail during the presentation, both regarding expansion in Coles and continued growth since launching in Woolworths Supermarkets Australia-wide as well.

Zane Yoshida

executive
#5

One of the topics I'll bring up is that, in light of how well our products have done at retail here in Australia, there's potential upside and something to weigh as we consider U.S. retail among our next moves. Wholesale and Bulk Ingredients keeps delivering really robust growth throughout the business. This quarter we exited R&D with the confidence to build a second site alongside a toll processing partner here in Australia, which will serve rising demand from the United States and other markets. Thanks, Matt. So, as we announced during the quarter, December set a sales record for the Calmer Company. We closed December at $910,000 in revenue. U.S.A. sales rose 9% compared with the prior quarter. And naturally, that's driven in large part by extremely strong growth in our wholesale channel too. As I mentioned earlier, the U.S.A. now accounts for a 51% share of total group revenue. Australian retail had a weaker quarter, mainly owing to the Q1 FY '26 pipeline fill into Woolworths Supermarkets, which Matt will go into in more detail. Thanks, Matt — over to you.

Matthew Kowal

executive
#6

I think you might want to dig a bit deeper into this one, Zane, or should I take it? Yes. So just carrying on from what Zane said, specifically about the U.S. and...

Zane Yoshida

executive
#7

To carry on with U.S.A. Yes, sorry about that, Matt — I think my connection isn't great this morning, so please go ahead.

Matthew Kowal

executive
#8

Yes. So picking up where Zane left off, and really the way U.S.A. emerged in sales volume last quarter, but more importantly what that signals about the opportunity ahead across all categories. Obviously, Amazon is already demonstrating a strong opportunity for us and continued growth, especially the year-on-year figures, very impressive. And we've taken some key steps there, as we'll discuss a bit later on in one of the slides, in terms of building up that second brand with Taki Mai. But alongside that opportunity we're seeing in online and Amazon is the emergence of wholesale, particularly obviously in the products we've just brought to market with CO2 extracts and their suitability to the market, as well as the growth of kava as an ingredient, not just into a complementary medicine, but into mainstream consumption, which has really seen immediate effect, but also what we can see in a short to medium opportunity for us as well. And that's also then the next step of the question that Zane touched on, which is how do we then explore what that means into a retail space, something we haven't done in the U.S., but it's something we're looking at with a great deal of detail to make sure that we execute well as we see the U.S.

Matthew Kowal

executive
#9

That represents an enormous opportunity for the company.

Zane Yoshida

executive
#10

Yes, and there was another positive development in the U.S. during the quarter, Matt — the major announcement from the FDA on the regulatory side. So now, at the federal level, Kava is regulated as a food. Just yesterday, word came through that California has recognized Kava as GRAS — generally recognized as safe. That's another important breakthrough, since California is by far the biggest state in the U.S., and it's very good news for Kava bars and for Kava consumers across the country generally. Beyond that, 10.7% of Americans have tried Kava more than once over the last 12 months. Most of them have bought Kava online — whether from us on Amazon USA or through retail Kava bars across the U.S.A. — so this is very, very good news for the industry and for the Calmer Co.

Matthew Kowal

executive
#11

Absolutely, absolutely. Speaking about retail and some of the points Zane raised earlier — again, it was a really strong quarter, especially considering that Q1 included a pipe fill into Woolworths, and also a pipe fill into Coles that expanded our 150-gram range as well. So we're seeing that growth year-on-year, but that trend across the year has also been really positive. Then we've picked up some new data directly from Scan to understand where we sit in the category. And as a stress subcategory, we rank #1 and #3 with our products at 50-grams and then the 50-grams. So that's incredibly strong reinforcement of what we're doing and shows the importance through the category and Kava growth in that retail space in general, contributing 33% of that subcategory. So the important part of that is it gives us an opportunity and a platform for growth and for talking with our retail partners. And that includes currently going through the range reviews. We recently submitted into Coles in their process, coming in for a midyear change in 2026. I think the important part of that is not only the extension opportunities around our current powders, but the introduction of some new products that we are working on and importantly, in a flavored and also convenience space, which really is going to give an opportunity to build on what we've done, but expand into a broader market where we can see that extra growth both in retail, but broadly across all forms of sale with this new flavor format.

Matthew Kowal

executive
#12

Beyond that, the Woolworths review cycle is scheduled to land in Q4 FY '26. Given the positive growth we've seen so far, we see <<inaudible>> a real chance to strengthen where we stand throughout Australian retail and to keep ourselves in a spot where we can consistently steer that Kava conversation. As Zane mentioned, this is the moment — with everything we're picking up from the Australian operation, what we can observe at Amazon, the trends, plus handling developments in the U.S. — to take a closer look at the U.S. It's an enormous market, so we have to approach it with a highly defined plan and make sure we align well with the right retail partners we enter with. That's in the pipeline right now. Later I'll address a bit more of the questions that have come through about what that will look like. E-commerce, as I noted, remains the foundation of our business, and that will stay true not just on the sales side but also for marketing and communication. It's clearly the simplest, quickest route to consumers and a strong opportunity to share, through that medium, still and video content covering what we do, the benefits of Kava and our superior products.

Matthew Kowal

executive
#13

I think the main thing to focus on for this past quarter is how Taki Mai has taken off in the U.S. and on Amazon. What matters here is being able to reach a broader market and figure out how to use our strategic edge with regional supply across different formats under both the FijiKava brand and the Taki Mai brand, plus the excellent work Andy has done in just under 12 months since joining — managing Amazon and growing Taki Mai from 7% to consistently above 40% of our revenue while also keeping Fiji Kava and its position intact. So we're now at a point where we can truly capitalize on some of those strategic plays we've discussed regarding our pillars going forward. On top of that, we recognize how important this channel is given its dual role in both sales and marketing. Because of that, we've engaged an outside consultant who specializes in Amazon and the marketing advertising side to make sure everything from our product through to our shops is performing and that our investment there delivers the best possible return.

Matthew Kowal

executive
#14

That will also be backed by investment from within the company, centered heavily on managing quality content and keeping that stream flowing continuously—which matters so much for engagement, both on Amazon and across all our other online platforms too. On wholesale, Zane, I believe you'd like to mention a few points regarding the toll processing side before I go into a bit...

Zane Yoshida

executive
#15

As I mentioned before, during the quarter we brought on a second facility in Australia to produce our CO2 extracts. We collaborated with them over the quarter and successfully shipped our first volumes into the United States. That comes on top of a strategic processor in India we've been partnering with, and in the quarter we also moved past the R&D phase there, with confidence that we can hit the yields and carbolactone levels needed for standardization in this channel. We've also seen success — repeat orders from beverage customers in the U.S.A. on this front — and we look forward to continued strength through the quarter and in the years to come.

Matthew Kowal

executive
#16

Definitely, definitely. And I believe that following the time and money we've put into those new products and toll processing partners, plus a really strong emphasis on Pillar 1, we're now in a position to build this new channel. And as the quarter-on-quarter results show, the opportunity keeps getting bigger. Alongside that, importantly, we're putting a lot of effort into developing a mix and a healthy balance of strategic partners and resellers, IMCD among them, so we can reach each of the sub-channels out there as effectively and as widely as possible. That's also backed by direct relationships with brands or manufacturers where we see we can add value to them straight away and where we either already have an established relationship or can control it going forward. So what matters here is the opportunity in front of us. We're making sure the volume we bring in through Pillar 1, in terms of both quality and access, means we have partners who can get it to market as fast as possible to keep up the momentum we can already see happening in Q1 and Q2 of this financial year.

Zane Yoshida

executive
#17

Cash on hand at the bank finished the quarter at a bit more than $1 million. During that same quarter, we also announced that the second tranche of the convertible note had closed. Inventory held steady at roughly $1.7 million across the quarter, with many of the new product formats now sitting in our 3PL in Houston, Texas. Subscriptions are definitely climbing. As Matt mentioned, Andy has done a tremendous job. On Amazon USA, subscriptions now stand at about 32% and are growing, which is a very strong position to be in, and that represents $200,000 of inventory already presold on that front. RTD formats keep expanding. Our flavored kava formats launched in the U.S.A. now account for roughly 5% of our revenue mix and are a key piece of our growth plan into FY '26 and beyond. The team stayed highly disciplined on spend. We have also trimmed operational costs further across the business as we continue on our path to -- and build momentum toward breakeven. Thanks, Matt. All in all, December stood out as an exceptional month for the Calmer Co, with record monthly revenue of $910,000. Our wholesale channel, which we discussed earlier, is putting up very strong performance so far.

Zane Yoshida

executive
#18

Revenue so far this year has already exceeded the entire FY '25 results, and that underscores how worldwide appetite keeps accelerating for premium, fully traceable kava ingredients. Momentum in the United States gives us a lot of encouragement. More than 50% of revenues are now generated in the U.S.A. Some quite encouraging developments are emerging from the U.S.A., where we made the market announcement regarding a regulatory shift from the FDA, which recognizes Kava as a food at the federal level. And as I mentioned, only yesterday, the state of California announced its recognition of Kava as GRAS, which represents a huge win for the industry. That connects with the regulatory framework we keep establishing, not only in Fiji but throughout the Pacific. In Fiji, we are now advancing to the next stages with the Fiji Kava Bill, which truly provides the industry a strong foundation from which to scale. And most importantly, as I keep saying during these webinars, it is about us continuing to satisfy demand, while making sure the quality we keep exporting from Fiji and the Pacific meets international food safety standards, along with complementary medicine status in the Australian market and dietary supplement status in the U.S.

Zane Yoshida

executive
#19

That's true for the market too. It's about making sure the highest-quality Noble Kava from the Pacific is what we send into export markets. So this is really, really great news for the Calmer Co, and for the Kava industry.

Zane Yoshida

executive
#20

Alright, at this point let's turn to a few questions. Matt, let me bring that up. I believe the first one concerned regional supply. And I suppose kava prices have been rising in the news recently. Is there any supply constraint in certain areas of the Pacific? And how are you safeguarding CCO momentum against those effects? The regional sourcing strategy is definitely central to this. Thanks to the Yaqona census carried out in 2024, we certainly have plenty of kava planted in Fiji. Roughly $1.3 billion in asset value of kava is estimated to be in the ground and ready for harvest. Across the last 12 months, we consumed and exported a combined $191 million worth of kava during that period. But above all, the regional sourcing strategy — which lets us bring in kava from nations such as Papua New Guinea, the Solomon Islands, Vanuatu, and now SMO, with SMO able to export into Fiji — gives us the strength to weigh and hedge against any volatility that might exist when it comes to risk from adverse weather or price increases as well.

Zane Yoshida

executive
#21

Beyond that, the approach we mentioned before is now paying off — namely the resurgence and the balanced revenue division between the Fiji Kava brand and the Taki Mai brand — and that matters a great deal in this assessment. At present, Taki Mai holds steady at roughly 40% of revenue on Amazon USA. The U.S.A. now accounts for 51% of our total revenue this quarter, without question. We regard the Taki Mai brand as the regional Kava brand, and it keeps going from strength to strength. On Amazon USA, back when Andy came on board early last year, our market share there stood at around 2% to 3%. That, taken together with Taki Mai and Fiji Kava, now makes up approximately 8% to 9% of all sales on Amazon USA — a fantastic outcome for us. The second question concerned e-commerce, Matt, and I'll hand that over to you. E-commerce is a hugely important piece of CCO's business, as we announced during the quarter. How do you sustain the momentum and growth across DTC and Amazon USA through the rest of the year?

Matthew Kowal

executive
#22

Yes. Look, I think I covered part of this on the slide. I think a key part of grasping why e-commerce matters is also grasping our capacity to convey our quality, our supply, our distinctive capability to deliver the finest kava from across the breadth of the Pacific. And so, we've ensured that beyond treating it as a sales channel, we're backing it even more strongly from a marketing and advertising standpoint. So I suppose from a top-of-the-funnel perspective when it comes to content, the internal investment includes a new content director who will oversee all channels but keep a really strong emphasis on online, making sure that imagery, the communication, the dialogue we're having is continually strengthening that platform and strengthening our communication and our tools for people like Andy and our new consultant on the Amazon side, Joel, when it comes to delivering on the advertising and marketing front. The other piece we've both mentioned is really knowing which are the key products that people are seeking, knowing the continuing growth of traditional formats and a solid cornerstone anchor within that, while leveraging our remarkable nimble capability through vertical integration to get the right products onto shelf fast.

Matthew Kowal

executive
#23

Flavored kava solutions — whether ready-to-drink or on-the-go — and ensuring we launch them at the correct price and the correct moment. There are two really crucial elements to what we're doing. I think we've also kind of mentioned how we position them to succeed and build that customer base that's strongly connected to us, and we can — by using things like subscriptions on Amazon, but also that same approach across both DTC and Amazon — create an ongoing and expanding community that's very much tied to Fiji Kava and the Taki Mai brands and what we're doing as an overall business.

Zane Yoshida

executive
#24

Matt, here's another one for you. Turning to retail: things are going nicely with Coles. How much interest is there in bringing on additional Australian retailers? And what's the reason for not pursuing the same approach in the U.S.A.?

Matthew Kowal

executive
#25

Why not indeed? Why not indeed? Look, I believe there are two genuinely valid points there, and in both areas we're actively devoting energy. So with Australia, the first piece is really about solidifying that position as the leader in retail. We've done a great job with Coles, but now we're looking to build on that, as I said, with a broader flavored offering and bringing new customers into that category, really rounding things out with Woolworths to bring them up to a similar level as Coles and that understanding of — when we're talking about 67% of grocery sales, having those 2 locked down then gives us a position to strategically look into other channels, and probably the one that's most interesting at the moment to explore is in that sort of, I guess, retail pharmacy space, along with understanding geographically, when I look at our friends across in New Zealand, where there's the opportunity there to sort of take control of that whole Australia and New Zealand space. The next part, I think, really comes into that opportunity that the U.S. presents. But as I said, I very much preface that with making sure that we're doing the right levels of investigation and making sure we go with the right partners.

Matthew Kowal

executive
#26

The space is enormous and covers a lot of ground. You can very easily overextend yourself. As I mentioned, we have an internal expression — inch-wide mile deep — and that is very much how we intend to tackle retail in the U.S. That way, once we find the right success, we can speed up and scale fast. Probably the main things to bear in mind there: we have pinpointed where the opportunity lies, and that is the reason we have put investment into having a presence at Expo West — the largest natural products expo anywhere in the world — a genuine chance to meet the retailers and the other sales formats that will be crucial as we move into the U.S., to grasp what their expectations are and to make certain we line up with the ability to serve them properly, while choosing the right partners to begin with. That, together with some early effort on a few of the B2B marketplaces that exist in the U.S., so that we again carry out the appropriate degree of investigation before we seek to speed up very rapidly once we have the correct plan to carry out.

Zane Yoshida

executive
#27

Yeah, absolutely. Thanks, Matt. The final question had to do with wholesale. So this is probably something that both you and I can take a crack at. It's really encouraging to see wholesale growing. How does CCO stay on top of that opportunity and avoid falling behind compared with others — other big pharma ingredient companies? I think the key here is the fact that we're based in the Pacific, we've got strategic partners throughout the region, and we've locked in supply agreements with the bigger exporters from regional locations. Another important piece we need to weigh here is that we have complete traceability and transparency. We're not simply purchasing cover in bulk and turning it into an extract format, for instance, without vetting quality assurance, standardization of the material, and making sure we genuinely export the finest quality extract formats heading into the United States. That's very clear to me given the confidence we have with beverage partners in the U.S.A. who have now, across roughly the last 9 months, come back to order repeatedly for this type of format. It speaks to the ingredient's quality. It speaks to the price-wise competitive advantage we hold, leveraging the fact that we're Pacific-based and we have a comprehensive supply chain to support the scale and our next steps with this channel in particular.

Matthew Kowal

executive
#28

Yes, absolutely. To build on what Zane mentioned, especially regarding R&D, product development, and strategic partnerships — I believe that flows directly into our sales efforts: cultivating strong ties with direct partners, while also grasping the wider potential in what is a vast market with numerous channels we can draw in. That means holding conversations and maintaining relationships with a range of resellers and distribution opportunities, so we can leverage the excellent work already accomplished in regional sourcing and quality development — activating it and scaling it as rapidly as we can.

Zane Yoshida

executive
#29

Yeah, that's right — I believe that wraps up the questions. Matt, is there anything else we should perhaps think about regarding what we've discussed today? I think it's about keeping the momentum going. For me, the main highlights are the added strength in our regional sourcing strategy, the traction we're seeing now that the regulatory framework is in place in both the U.S. and with the Fiji Kava Bill being prepared in Fiji. We're hopeful there'll be some progress on that front through the Australian Kava Commercial Import trial. The Calmer Company is certainly lobbying continuously on that, to make sure the Kava commercial pilot trial gets finalized, and for greater flexibility there too, so that we achieve harmonization with the standards currently in place across the ditch with our New Zealand friends. And then, naturally, we'll keep examining opportunities outside direct-to-consumer, Amazon in the U.S. included. Matt mentioned retail opportunities earlier, but we have to approach this very strategically. The U.S.A. is a beast, and we need to think very carefully about how we'd approach it — whether on a regional basis, dipping our toes in first to see how that looks, and understanding how we could potentially scale up to meet what we believe is very strong, ongoing demand in the United States.

Zane Yoshida

executive
#30

Access to the European Union market also remains front and center in the work we're doing with our friends at The Pacific Island Forum Secretariat. On EU market access, I believe the team made a visit into Europe last quarter as well, to keep knocking on the door, given the quality framework we now have in place through Codex Alimentarius. And now, as I said, the Fiji Kava Bill finally coming to finalization will add further confidence with markets like the EU and beyond, allowing access once again for Kava into those regions. What else is there, Matt? Wholesale, for me, is very exciting. It's a very high-margin part of our business, and we're looking to add further strength there now, given the confidence we have internally with the results we've been getting, that we've optimized over the last 6 to 9 months now from an R&D perspective. Anything you'd like to contribute further there, Matt?

Matthew Kowal

executive
#31

You gave a really solid summary of what we're doing, and of course some of the opportunities in Europe that haven't come up yet. So to back up each of those pieces and build on what you said, I think how we approach these things matters a great deal — which is why we test where the focus should be, and then push ahead strategically once we can see that we've got the full capability, or the full opportunity, right there in front of us.

Zane Yoshida

executive
#32

Sure thing. Thanks, everyone. I appreciate you being with us on this webinar for Q2 of FY '26. Thanks, Matt. Hope you all have a really good Friday and a great weekend.

Matthew Kowal

executive
#33

Same here, and thanks to all of you.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete The Calmer Co International Limited transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to The Calmer Co International Limited earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in The Calmer Co International Limited or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.